Registered entities
Silverback Therapeutics, Inc.
Reg. No. 81-1489190United States
Innovation
26 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,054 times.
| Year | Filings |
|---|---|
| 2018 | 5 |
| 2019 | 9 |
| 2020 | 13 |
| 2021 | 16 |
| 2022 | 13 |
| 2023 | 3 |
Investor mix
18 investors on record; lead investors include USVP, Orbimed, EcoR1; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 39% |
| Private equity | 4 | 22% |
| Other / undisclosed | 7 | 39% |